26 It is also feasible that reduction in AMD risk factors such as obesity, cardiovascular disease, and hyperlipidemia with GLP-1RAs could further provide benefit by reducing systemic inflammation and vascular risk factors
Mowery et al., Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice, Molecular Metabolism 63 (2022) 101533
The modeled spectral range was from 0.2 to 4.2 ppm
But state laws can override federal permissions
These conditions can reshape daily life by limiting what patients are able to eat, requiring ongoing medical treatment, and creating significant financial strain
Fat loss momentum stops, and without the enhanced lipolysis from elevated GH, maintaining achieved body composition requires more attention to diet and training